Leaders say they want innovation, yet reward speed and predictability. Learning from nature shows how curiosity and culture ...

The path to AI success starts with a single, well-chosen use case: one that is bold enough to inspire, urgent enough to ...

AI isn’t stuck because of tech — it’s stuck because of fear. This guide shows CIOs how to turn stalled pilots into real ...

Generative AI (GenAI) has moved rapidly from experimentation into day-to-day use across many organizations. Over the past ...

What is chain-hopping? Know why moving funds across incompatible L1 blockchains creates blind spots for AML tools and ...

Regulatory changes from the EPA have catalyzed significant innovations in gas chromatography, enhancing analytical ...

Secured 3-year deal with Blue Origin to provide precision honeycomb core supports program maturity.

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

What makes Vivek Shah's story resonate so deeply is that his commitment to quality and alignment extends far beyond the realm ...

Build a low-power smart sensor system with a tailored board, MOSFET switching, and ESP32 deep sleep, giving up to 1.7 years usage between charges ...

Like many companies, Ernst & Young and Lumen have been working to bring AI tools and services into their respective operations. But they’ve taken very different approaches to find success.

Late last year, Enterprise Times spoke to Arturo Buzzalino, Chief Innovation Officer at Epicor. Buzzalino started his career as a data scientist and spent ...